by | Sep 2, 2025 | Lupus Foundation of America, News & Events
A new study found that both lupus anticoagulant (LA) and anti-β2 glycoprotein I (β2GPI) IgG/IgM antibodies had predictive value for adverse pregnancy outcomes and complications, specifically early-onset pre-eclampsia and intrauterine fetal death, in healthy, pregnant...
by | Aug 29, 2025 | Lupus Foundation of America
The Lupus Foundation of America has published a new study in the latest issue of Arthritis Care & Research identifying high-impact solutions that address inequitable health outcomes in lupus due to adverse social determinants of health.Addressing health and...
by | Aug 27, 2025 | Lupus Foundation of America
The Lupus Foundation of America is pleased to announce the recipients of the 2025 Gary S. Gilkeson Career Development Award (CDA). The two-year grant supports critical lupus research conducted by early career scientists and provides mentorship to guide their studies...
by | Aug 20, 2025 | Lupus Foundation of America
For National Skincare Awareness Month, Ashara Collie is sharing her journey of being diagnosed and living with discoid lupus – a type of lupus that affects the skin and often causes round, disc-shaped rashes. For her, it began with small, itchy patches on her face and...
by | Aug 18, 2025 | Lupus Foundation of America, News & Events
A new study suggests preload deficiency could be the underlying cause of fatigue and exercise intolerance in people with systemic lupus erythematosus (SLE). Preload deficiency is a condition where the heart’s capacity to fill with blood before pumping (preload)...
by | Aug 14, 2025 | Lupus Foundation of America, News & Events
In a new study, systemic lupus erythematosus (SLE) disease severity indicated by the presence of lupus nephritis, (LN, lupus-related kidney disease) and other SLE risk factors contributed to reduced bone mineral density (BMD) and an increased risk of osteoporosis....
